Stocks
Abbott LaboratoriesABT
NYSEHealthcareMedical Devices & Diagnostics$108.03-0.11%
A diversified medical products manufacturer focused on diagnostics, medical devices, nutrition products, and branded generic pharmaceuticals. Its portfolio includes cardiovascular devices, diabetes monitoring systems such as FreeStyle Libre, and laboratory and rapid diagnostic testing platforms used...
Market Cap: $187.7B52W Range: $105.27 – $139.06
Congressional Interest in Abbott Laboratories (ABT)
14 members of Congress have disclosed 50 trades in Abbott Laboratories (ABT), a Healthcare company. The buy/sell breakdown shows 22 purchases versus 28 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
14
Buys
22
Sells
28
Who in Congress Is Trading ABT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-09-26 | Greg Stanton | buy | $1K – $15K |
| 2023-09-21 | John P Ricketts | sell | $100K – $250K |